In recent years,the state has proposed key support and prioritized development of healthrelated aspects and introduced relevant specific policies such as " Homology of Medicine and Food ".In this context,the implementation of project innovation in hospital of traditional Chinese medicine has also become a "Blue Ocean" for related enterprise to achieve higher yields and rapid growth.Thispaperisthe business plan of DT.Based on Chinese medicine theory of medicine food homology,DT is a innovative project which including R&D ?production and sale.DT product is a high-end biology drink with several polysaccharides and oligopeptides for cancer patients and sub health group.The up-front investment of DT is 10000000 RMB.The product is expected to hit the market at the end of 2017,and the predicting sales for 4 years is 150 million.The aim of this paper is to analyze the feasibility and risk assessment of DT project.By producing investors and the main conditions,analyze the market condition,operation strategy,organizational structure,staffing,financial situation and risk control,using the theoretical knowledge,to proof DT project is a good business plan with great economic return,it is feasible and will create a blue sea market. |